Birth control apps show the contradictions in FDA device oversight
The FDA says two types of digital birth control are the same, but one company disagrees
Share this story
Digital birth control company Natural Cycles wasn’t happy with the news that the Food and Drug Administration cleared a second birth control app at the start of the month. The company, which was the first to get sign-off from the agency, says it’s glad to have the competition but it takes issue with the
way the FDA gave the new app, made by Clue, the okay.
The FDA can allow products to be sold and marketed in the US if they’re similar enough to something already available to consumers. In this case, the FDA is saying Clue is “substantially equivalent” to Natural Cycles similar enough to earn the agency’s green light. But Natural Cycles doesn’t agree. “I feel this is slightly concerning,” Natural Cycles CEO Elina Berglund told
House committees push out bill on chemical abortion reversal | News, Sports, Jobs theintermountain.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theintermountain.com Daily Mail and Mail on Sunday newspapers.
CHARLESTON â Without any testimony from an expert, the West Virginia House of Delegatesâ Health and Human Resources Committee on Tuesday passed a bill requiring physicians provide information about stopping the process of a medicated abortion.
House Bill 2982, or the Second Chance at Life Act, as amended by the committee, requires a patient undergoing a medication-induced abortion to be informed that it may be possible to stop the effects of the procedure after taking the first of the two drugs.
The state Department of Health and Human Resources will also have to post information about stopping the procedure.
The bill is similar to other anti-abortion legislation thatâs passed in at least six states, though HB 2982 does not require physicians to advise the procedure can be âreversedâ but does say itâs possible to âavoid, cease or even stop the intended effects.â
Joanne Cross, Director of Marketing N+1 Singer (Joint Corporate Broker) Tel: +44 (0)20 7496 3000 Aubrey Powell / Tom Salvesen / George Tzimas Stifel Nicolaus Europe Limited (Joint Corporate Broker) Tel: +44 (0)20 7710 7600 Nicholas Moore / Matthew Blawat / Ben Maddison Walbrook PR Ltd (Media and Investor Relations) Tel: +44 (0)20 7933 8780 or [email protected] Paul McManus / Lianne Cawthorne
About Yourgene Health Yourgene Health is an international molecular diagnostics group which develops and commercialises genetic products and services. The group works in partnership with global leaders in DNA technology to advance diagnostic science. Yourgene primarily develops, manufactures, and commercialises simple and accurate molecular diagnostic solutions, for reproductive health, precision medicine and now in
Doctors debate use of blood thinners to prevent clots in women after C-sections news-medical.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from news-medical.net Daily Mail and Mail on Sunday newspapers.